Please ensure Javascript is enabled for purposes of website accessibility Biotech & Healthcare Market Outlook 2026 | Janus Henderson Investors | LatAm Other Advisor
For professional investors in Latam - other countries

Biotech & Healthcare Market Outlook 2026

Please watch our Portfolio Manager, Daniel Lyons, and Client Portfolio Manager, Sean Carroll as they explore the key factors driving a potential rebound across the markets, including the rise of precision medicine and advanced therapies, clarity on the policy and regulatory environment, and the impact of renewed M&A activity.

28 Jan 2026
35 minute watch

These are the views of the author at the time of publication and may differ from the views of other individuals/teams at Janus Henderson Investors. References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.

 

Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

 

The information in this article does not qualify as an investment recommendation.

 

There is no guarantee that past trends will continue, or forecasts will be realised.

 

Marketing Communication.

 

Glossary